Cure Today

First-Line Enhertu Combo Gets Priority Review in HER2+ Metastatic Breast Cancer

Enhertu plus Perjeta received FDA priority review for first-line treatment of HER2-positive metastatic breast cancer, showing significant improvements in progression-free survival and response rates.
Hosted on MSN

Use nimesulide only after exhausting first-line options—expert panel under drug regulator CDSCO

New Delhi: A committee under India’s apex drug regulator has recommended against using the popular painkiller nimesulide, or its above-100mg dosage strength in oral formulations, as the first line of ...
The American Journal of Managed Care

Real-World Study Finds Brentuximab Vedotin With Chemo Is Safe, Effective in First-line Treatment of PTCL

Brentuximab vedotin with CHP is effective and safe for first-line PTCL treatment, achieving an 80% overall response rate. Median progression-free survival was 39.7 months, with a 1-year overall ...
Cure Today

First-Line Keytruda Combo Elicits OS Results in Head and Neck Cancers

Keytruda and Efti combination therapy achieved a median overall survival of 17.6 months in head and neck squamous cell carcinoma with PD-L1 CPS less than one. The combination therapy demonstrated a ...
Business Insider

ArriVent Announces First Patient Dosed in Global Pivotal Phase 3 ALPACCA Trial Evaluating Firmonertinib for First-Line Treatment of EGFR PACC Mutant Non-Small Cell Lung Cancer

Firmonertinib has the potential to redefine first-line treatment in this underserved population as a once daily, oral, brain-penetrant, chemo-free monotherapy ALPACCA pivotal trial is designed to ...